We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
-$36.6M
Cap. Flow
-$73.8M
Cap. Flow %
-0.42%
Top 10 Hldgs %
30.57%
Holding
716
New
41
Increased
319
Reduced
225
Closed
41

Top Buys

Rank Stock Value
1
WM icon
Waste Management
WM
+$59.7M
2
MSFT icon
Microsoft
MSFT
+$55.1M
3
MA icon
Mastercard
MA
+$53.2M
4
LRCX icon
Lam Research
LRCX
+$52M
5
WMT icon
Walmart Inc
WMT
+$52M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$71.1M
2
UNH icon
UnitedHealth
UNH
+$65.8M
3
AMGN icon
Amgen
AMGN
+$58M
4
IQV icon
IQVIA
IQV
+$50.8M
5
CSCO icon
Cisco
CSCO
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 33.5%
2 Healthcare 24.06%
3 Financials 11.65%
4 Consumer Discretionary 8.41%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.89T
$1.12B 6.47%
2,667,188
+129,449
+5% +$55.1M
NVDA icon
2
NVIDIA
NVDA
$5.19T
$948M 5.46%
7,061,058
+35,684
+0.5% +$4.92M
AAPL icon
3
Apple
AAPL
$4.76T
$888M 5.12%
3,547,896
-10,580
-0.3% -$2.49M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.25T
$523M 3.01%
2,764,393
-406,530
-13% -$71.1M
AMZN icon
5
Amazon
AMZN
$2.62T
$444M 2.56%
2,023,771
+213,039
+12% +$43.6M
LLY icon
6
Eli Lilly
LLY
$1.04T
$405M 2.33%
524,212
+18,313
+4% +$15.2M
MA icon
7
Mastercard
MA
$473B
$271M 1.56%
515,594
+102,714
+25% +$53.2M
AVGO icon
8
Broadcom
AVGO
$1.89T
$262M 1.51%
1,131,537
+17,154
+2% +$3.17M
CRM icon
9
Salesforce
CRM
$134B
$222M 1.28%
663,879
+12,815
+2% +$4.09M
MRK icon
10
Merck
MRK
$316B
$221M 1.27%
2,217,423
-248,291
-10% -$25.6M
TMO icon
11
Thermo Fisher Scientific
TMO
$194B
$212M 1.22%
407,490
+78,512
+24% +$43.2M
PG icon
12
Procter & Gamble
PG
$350B
$211M 1.21%
1,257,669
+187,839
+18% +$32M
V icon
13
Visa
V
$677B
$192M 1.11%
607,148
-131,870
-18% -$39.7M
UNH icon
14
UnitedHealth
UNH
$393B
$192M 1.1%
379,181
-115,757
-23% -$65.8M
TSLA icon
15
Tesla
TSLA
$1.42T
$190M 1.1%
470,991
+71,575
+18% +$23M
REGN icon
16
Regeneron Pharmaceuticals
REGN
$68.4B
$186M 1.07%
261,498
+8,973
+4% +$7.53M
WM icon
17
Waste Management
WM
$94.8B
$185M 1.06%
916,273
+277,916
+44% +$59.7M
JPM icon
18
JPMorgan Chase
JPM
$926B
$183M 1.05%
763,517
+222,056
+41% +$51.7M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.24T
$179M 1.03%
941,072
-53,266
-5% -$9.4M
TSM icon
20
TSMC
TSM
$2.19T
$171M 0.99%
868,112
+4,101
+0.5% +$794K
AMGN icon
21
Amgen
AMGN
$198B
$161M 0.93%
617,525
-195,571
-24% -$58M
GILD icon
22
Gilead Sciences
GILD
$163B
$159M 0.92%
1,723,316
-364,971
-17% -$32.9M
NOW icon
23
ServiceNow
NOW
$99.5B
$144M 0.83%
678,680
-171,950
-20% -$34.8M
HD icon
24
Home Depot
HD
$332B
$141M 0.81%
363,687
+9,156
+3% +$3.74M
EMR icon
25
Emerson Electric
EMR
$78.3B
$140M 0.81%
1,130,641
+86,474
+8% +$10.5M

Similar funds

Candriam SCA's Q4 2024 Portfolio in Review

As of Q4 2024, Candriam SCA held 716 positions worth $17.4B, down 0.21% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q4 2024 filing shows 41 new, 319 increased, 225 reduced and 41 closed positions. Its largest new stake was Lam Research: 685,631 shares worth $49.5M. The largest sale was Alphabet (Google) Class A, an estimated $71.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2024 buy was Lam Research: 685,631 shares worth $49.5M.
  • Candriam SCA added most to Waste Management in Q4 2024, an estimated $59.7M increase.
  • Candriam SCA's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $71.1M.
  • Candriam SCA fully exited Kanzhun in Q4 2024, selling an estimated $22.5M.
  • Candriam SCA's ten largest holdings make up 31% of its $17.4B portfolio in Q4 2024.
  • Candriam SCA opened 41 new positions and closed 41 in Q4 2024.
  • Candriam SCA's portfolio value fell 0.21% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.